D-0679-2026 Class II Ongoing
FDA drug recall D-0679-2026 was initiated by Bell Pharmaceuticals, Inc on Jun 25, 2026 and is designated Class II. Reason for recall: SubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6 7%). The recall status is ongoing. Affected quantity: 29, 474 units.
Recall details
- Product Type
- Drugs
- Report Date
- Jul 22, 2026
- Initiation Date
- Jun 25, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 29, 474 units
Product description
Clinere, Carbamide Peroxide, a) 2 bottles of Clinere Carbamide Peroxide (2 x 0.50 mL) 6.5%, 0.5 fl. oz. (15 mL); b) 1 bottle of Clinere Carbamide Peroxide (0,50 fl. oz. (15 mL), Dist. by: Quest Products LLC, Pleasant Prairie, WI 53158, NDC 68229-102-01.
Reason for recall
SubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6 7%).
Distribution pattern
U.S Nationwide
Code information
Lot: a) 1504241, exp 2027-03; b) 1504291, 1504301, exp 2027-03.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0679-2026
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026